Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
Gross Profit
Rosetta Genomics Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Gross Profit
$1.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Gross Profit
$9.8m
|
CAGR 3-Years
46%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Gross Profit
$55.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Gross Profit
$73.4m
|
CAGR 3-Years
89%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Gross Profit
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rosetta Genomics Ltd's Gross Profit?
Gross Profit
1.8m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Gross Profit amounts to 1.8m USD.
What is Rosetta Genomics Ltd's Gross Profit growth rate?
Gross Profit CAGR 1Y
-10%
Over the last year, the Gross Profit growth was -10%.